This Ebola Drug ‘Works Great In Monkeys In The Lab’, But It’s Being Held Up By The FDA
Julie Steenhuysen
BusinessInsider.com
Aug. 3, 2014
CHICAGO (Reuters) – The worst Ebola outbreak in history is heaping new pressure on U.S. regulators to speed the development of treatments for the deadly virus, which has killed more than 700 people since February.
The U.S. Food and Drug Administration on Friday said in an emailed statement the agency “stands ready” to work with companies and investigators working with patients “in dire need of treatment.”
A senior official within FDA told Reuters the agency would consider proposals for providing treatments under special emergency new drug applications, if the benefits of the treatment outweighed the potential safety risks.
The Rest…HERE
